Weight-loss drug shows promise for patients on antipsychotics
Disease control
Ongoing
This study tests whether semaglutide (Wegovy), a weight-loss injection, can help people who take antipsychotic medications and are obese. About 20 adults in a secure mental health hospital will receive the drug along with diet, exercise, and psychological support for 24 months. T…
Phase: PHASE4 • Sponsor: St Andrew's Healthcare • Aim: Disease control
Last updated May 11, 2026 20:46 UTC